Nuvation Bio Inc. - Common Stock (NUVB) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2021 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
NUVB on NYSE
Shares outstanding
339,200,672
Price per share
$8.96
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
116,877,327
Total reported value
$1,046,853,550
% of total 13F portfolios
0%
Share change
-9,518,706
Value change
-$53,034,209
Number of holders
150
Price from insider filings
$8.96
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Nuvation Bio Inc. - Common Stock (NUVB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +11% $110,306,310 +$11,583,764 50,599,225 +12% FMR LLC 31 Mar 2025
BlackRock, Inc. 6.4% +30% $42,332,244 +$10,273,842 21,708,843 +32% BlackRock, Inc. 30 Jun 2025

As of 31 Dec 2025, 150 institutional investors reported holding 116,877,327 shares of Nuvation Bio Inc. - Common Stock (NUVB). This represents 34% of the company’s total 339,200,672 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Nuvation Bio Inc. - Common Stock (NUVB) together control 32% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Decheng Capital LLC 7.7% 25,954,439 0% 31% $232,551,773
BlackRock, Inc. 7.3% 24,669,776 +0.27% 0% $221,041,196
VANGUARD GROUP INC 4.6% 15,555,606 +0.65% 0% $139,378,229
Laurion Capital Management LP 2.3% 7,852,638 -19% 4.8% $70,359,636
STATE STREET CORP 1.7% 5,858,782 -3.8% 0% $52,494,687
GEODE CAPITAL MANAGEMENT, LLC 1.7% 5,712,296 -3% 0% $51,191,720
ABRAMS CAPITAL MANAGEMENT, L.P. 1.1% 3,811,513 0% 0.6% $34,151,156
Nuveen, LLC 0.84% 2,852,001 -38% 0.01% $25,553,930
DIMENSIONAL FUND ADVISORS LP 0.61% 2,066,360 -38% 0% $18,514,586
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.59% 2,016,681 -1.9% 0% $18,069,462
GOLDMAN SACHS GROUP INC 0.5% 1,696,013 +41% 0% $15,196,276
Capricorn Fund Managers Ltd 0.47% 1,588,854 3.4% $14,236,132
MORGAN STANLEY 0.38% 1,276,128 -3.3% 0% $11,434,107
SymBiosis Capital Partners, LLC 0.37% 1,250,000 0% 12% $11,200,000
MARSHALL WACE, LLP 0.36% 1,234,273 +488% 0.01% $11,059,085
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.24% 819,632 +77% 0% $7,343,903
BNP PARIBAS FINANCIAL MARKETS 0.21% 702,017 0% 0% $6,290,072
Bank of New York Mellon Corp 0.2% 687,228 -5.6% 0% $6,157,564
UBS Group AG 0.18% 615,402 -32% 0% $5,514,002
JPMORGAN CHASE & CO 0.18% 595,045 -12% 0% $5,331,604
Neo Ivy Capital Management 0.17% 587,656 0.84% $5,265,397
CAXTON ASSOCIATES LLP 0.17% 584,935 +204% 0.1% $5,241,018
JANE STREET GROUP, LLC 0.16% 530,077 -77% 0.01% $4,749,490
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.15% 521,038 +40% 0% $4,668,501
Hennion & Walsh Asset Management, Inc. 0.13% 445,279 +31% 0.14% $3,989,700

Institutional Holders of Nuvation Bio Inc. - Common Stock (NUVB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 116,877,327 $1,046,853,550 -$53,034,209 $8.96 150
2025 Q3 220,565,926 $817,904,643 -$1,513,463 $3.70 202
2025 Q2 224,729,650 $439,155,420 +$34,613,471 $1.95 179
2025 Q1 207,335,118 $364,911,263 +$18,852,443 $1.76 159
2024 Q4 197,748,566 $526,027,669 +$38,581,638 $2.66 159
2024 Q3 187,137,100 $428,593,958 +$73,128,321 $2.29 153
2024 Q2 153,048,262 $446,948,909 +$52,594,408 $2.92 146
2024 Q1 134,652,746 $490,113,918 +$5,142,866 $3.64 122
2023 Q4 134,270,272 $202,718,680 -$2,287,216 $1.51 116
2023 Q3 136,892,011 $183,439,434 -$9,239,486 $1.34 122
2023 Q2 139,011,387 $250,194,724 +$3,219,600 $1.80 120
2023 Q1 137,479,282 $228,214,660 -$4,709,474 $1.66 126
2022 Q4 139,580,600 $267,992,788 -$12,224,298 $1.92 123
2022 Q3 141,780,239 $317,588,133 -$44,323,294 $2.24 116
2022 Q2 155,298,098 $503,167,223 -$21,514,875 $3.24 116
2022 Q1 159,104,350 $836,898,347 +$14,198,236 $5.26 112
2021 Q4 155,258,449 $1,319,350,594 +$21,011,876 $8.50 103
2021 Q3 151,280,175 $1,503,381,648 +$33,688,697 $9.94 97
2021 Q2 147,981,823 $1,364,632,796 +$15,849,184 $9.31 97
2021 Q1 145,559,447 $1,478,100,000 +$1,473,836,329 $10.45 72